Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. [PDF]
BMC Infect Dis, 2012 Obiero J +3 more
europepmc +1 more source
State of the science of adherence in pre-exposure prophylaxis and microbicide trials. [PDF]
J Acquir Immune Defic Syndr, 2012 Muchomba FM +3 more
europepmc +1 more source
Pregnancy incidence and risk factors among women participating in vaginal microbicide trials for HIV prevention: systematic review and meta-analysis. [PDF]
PLoS One, 2013 Musekiwa A +3 more
europepmc +1 more source
Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis. [PDF]
Antiviral Res, 2012 Date AA +6 more
europepmc +1 more source
Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002. [PDF]
Breast Cancer Res, 2002 Bernstein JL +2 more
europepmc +1 more source
Estimating the effectiveness in HIV prevention trials by incorporating the exposure process: application to HPTN 035 data. [PDF]
Biometrics, 2014 Zhang J, Brown ER.
europepmc +1 more source
HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. [PDF]
Int J Epidemiol, 2010 Baggaley RF, White RG, Boily MC.
europepmc +1 more source
Rectal pre-exposure prophylaxis (PrEP). [PDF]
Antiviral Res, 2013 Rohan LC, Yang H, Wang L.
europepmc +1 more source
Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro. [PDF]
Antiviral Res, 2010 Lai BE +4 more
europepmc +1 more source
ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. [PDF]
Br J Cancer, 2003 Bernstein JL +14 more
europepmc +1 more source